Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN1 SHORT NOTE 5M ★ High-yield

Define dysplasia and carcinoma in situ. Describe their features and significance.

Pathology · 2nd Professional — Para-Clinical

Definitions

TermDefinition
DysplasiaDisordered growth with loss of uniformity and of architectural orientation; a pre-malignant change
Carcinoma IN situFull-thickness dysplasia involving the entire epithelium, but with the basement membrane still intact
Invasive carcinomaMalignant cells have breached the basement membrane

Features of Dysplasia

  • Loss of uniformity of individual cells and loss of their architectural orientation
  • Pleomorphism — variation in size and shape
  • Hyperchromatic nuclei with a high nuclear:cytoplasmic ratio
  • Mitoses that are numerous and appear at all levels of the epithelium, not only in the basal layer
  • Loss of polarity — the orderly maturation from base to surface is lost
  • Graded as mild, moderate and severe by how much of the thickness is involved

Behaviour and Significance

GradeExtentBehaviour
Mild dysplasia (CIN 1)Lower third of the epitheliumUsually regresses spontaneously
Moderate dysplasia (CIN 2)Lower two-thirdsMay regress, persist or progress
Severe dysplasia (CIN 3)More than two-thirdsUsually progresses if untreated
Carcinoma IN situFull thickness; basement membrane intactProgresses to invasion in most cases over years; but is curable by complete local excision

CLINICAL PEARL

Carcinoma in situ has no capacity to metastasise, and that is the whole point of screening. There are no lymphatics or blood vessels above the basement membrane, so however malignant the cells look, they cannot spread while it is intact. Detecting and removing the lesion at this stage is completely curative.

Common Sites

  • Cervix — the transformation zone; detected by the Pap smear; the model for cancer screening worldwide
  • Bronchus — in smokers, following squamous metaplasia
  • Oesophagus — in Barrett mucosa
  • Stomach — in chronic atrophic gastritis with intestinal metaplasia
  • Skin — solar (actinic) keratosis; Bowen disease is squamous carcinoma in situ
  • Breast — ductal and lobular carcinoma in situ
  • Oral cavity — leukoplakia and erythroplakia; especially important in India

Applied Aspects

  • Dysplasia is reversible if the stimulus is removed, particularly the milder grades — stopping smoking or tobacco chewing genuinely reverses early lesions
  • Cervical screening detects the pre-invasive stage and has reduced mortality dramatically wherever it is well organised; India's low coverage is the chief reason cervical cancer remains so common here
  • Cytology cannot distinguish in situ from invasive disease, since it shows cells without their architecture — a positive smear must always be followed by colposcopy and biopsy
  • Erythroplakia carries a much higher risk of malignancy than leukoplakia and must always be biopsied
  • Ductal carcinoma in situ of the breast is now found chiefly by mammographic microcalcification, and is treated by excision with clear margins

All questions in Neoplasia

  1. Q1Define neoplasia. Describe the nomenclature of tumours and differentiate benign from malignant tumours. Add a note on anaplasia. ★
  2. Q2Describe the molecular basis of cancer. Discuss oncogenes, tumour suppressor genes and DNA repair genes with examples. ★
  3. Q3Classify carcinogenic agents. Describe chemical, radiation and viral carcinogenesis with examples. ★
  4. Q4Describe the routes of spread of malignant tumours. Explain the metastatic cascade and the factors determining the site of metastasis. ★
  5. Q5Describe the laboratory methods used in the diagnosis of cancer. Explain grading and staging and add a note on paraneoplastic syndromes. ★
  6. SN1Define dysplasia and carcinoma in situ. Describe their features and significance. ★
  7. SN2Define oncogenes. Describe the mechanisms of their activation with examples. ★
  8. SN3Describe the structure, function and significance of the p53 gene. ★
  9. SN4Describe the important tumour markers with their uses and limitations. ★
  10. SN5Describe tumour angiogenesis with its regulation and clinical significance. ★
  11. SN6Define teratoma. Classify teratomas and describe the ovarian mature cystic teratoma.
  12. SN7Describe the paraneoplastic syndromes with their mechanisms and associations. ★

Every Pathology chapter →

Scroll to Top